Tag Archives: PrEP

High rates of starting and staying on PrEP in pregnant South African women, despite barriers

High initiation and persistence on pre-exposure prophylaxis (PrEP) has been documented in pregnant women in Cape Town, South Africa, with 91% of those offered PrEP starting it and nearly half of those continuing to take PrEP six months later. While women who had given birth and those reporting side effects were less likely to stay… Read More »

Bacterial STI rates rose in the year before starting PrEP, but not during PrEP, Australian study finds

A study of gay and bisexual male participants in the first large implementation study of HIV pre-exposure prophylaxis (PrEP) in Australia has found that although rates of bacterial sexually transmitted infections (STIs) were high, they did not increase in the two years after starting PrEP. In contrast, they increased significantly in the year before men… Read More »

Is reducing anxiety a legitimate indication for PrEP in itself?

Australian doctors and nurses discuss PrEP’s role in tackling stigma, supporting U=U, and improving mental health Do doctors and other healthcare workers feel it’s legitimate to prescribe PrEP to people who are anxious about catching HIV, even if their actual risk is low? This question has been rarely been systematically asked of doctors and other… Read More »

PrEP and the trans community webinar

On Thursday 17 December (13:00 GMT/14:00 W Europe) PrEP in Europe is holding a webinar on PrEP and the trans community. Trans women and men worldwide need PrEP to protect them from HIV. This webinar combines scientific research by, and for, trans people on HIV and PrEP, and the recommendations from PrEP in Europe’s recent… Read More »

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

HPTN 084 study finds significantly lower adherence in women taking daily PrEP pills A second study of an injectable HIV drug used to prevent HIV has had its randomised phase stopped early after it became clear that giving women a two-monthly injection of a prevention drug resulted in nearly nine times fewer infections than giving… Read More »